ESC/ESH blood pressure guidelines: why US and European thresholds differ

A reading of 130/80 mmHg can be called hypertension in the United States and not hypertension in much of Europe. The measurement has not changed; the classification table has.

That difference explains much of the confusion around ESC/ESH blood pressure guidelines, the American College of Cardiology/American Heart Association (ACC/AHA) guideline, and the European categories shown in monitors, apps, and search results. The disagreement is genuine, but it concerns the point at which a label is applied—not a sudden biological change at 130/80 or 140/90.

Blood pressure risk rises along a continuum. A single reading cannot diagnose hypertension, and a category is not a prediction of what will happen to one person. Diagnosis rests on a repeated pattern, reliable technique, and readings interpreted in context, usually with home or ambulatory monitoring when appropriate.

The short answer: two tables, one continuous risk

The 2017 ACC/AHA guideline defines hypertension at 130/80 mmHg or higher. Its categories are designed to identify higher pressure earlier and to combine the reading with overall cardiovascular risk when discussing what follows.

The European Society of Cardiology (ESC) and European Society of Hypertension (ESH) have retained 140/90 mmHg as the office threshold for hypertension in their major guidance. Below that threshold, European tables identify normal and high-normal ranges rather than treating every reading below 140/90 as equivalent.

The central difference is this:

• ACC/AHA places readings from 130–139 systolic or 80–89 diastolic in a hypertension category.
• Traditional ESC/ESH places 130–139 systolic or 85–89 diastolic in the high-normal category and reserves the hypertension label for 140/90 or higher in the office.
• Both frameworks treat the category as one part of assessment, not as a diagnosis from one measurement.
• Both recognize that risk is affected by factors such as kidney disease, diabetes, smoking, cholesterol, previous cardiovascular disease, age, and frailty.

In the United States, ACC/AHA is the usual reference. Across Europe, a service may refer to the 2023 ESH guideline, the 2024 ESC guideline, or national guidance based on them. Other countries may use national guidance or recommendations from the International Society of Hypertension (ISH). The applicable framework is normally the one used by the local health system.

The reference tables compared

The table below compares the familiar 2017 ACC/AHA categories with the traditional 2018 ESC/ESH office categories. Blood pressure is classified by the higher category reached by either number. For example, 130/90 is not high-normal under ESC/ESH because the diastolic value reaches 90.

Under ESC/ESH, the normal range includes 120–129 systolic or 80–84 diastolic when the reading does not reach the high-normal band. Under both systems, the higher category applies if the systolic and diastolic numbers fall into different rows.

These are reference categories, not diagnoses. A single result from a home cuff, pharmacy machine, or office visit cannot establish hypertension. Repeated measurements, correct cuff placement, and the measurement setting all affect interpretation. Home and ambulatory readings can also show that office pressure is higher than usual (white-coat hypertension) or that pressure outside the clinic is higher than an office reading suggests (masked hypertension).

For a quick comparison, use the Blood pressure category checker (ACC/AHA and ESC/ESH). It shows why the same reading can receive different labels without implying that the measurement itself has changed.

Why the ACC/AHA guideline moved the threshold down

The 2017 ACC/AHA guideline drew on evidence showing a graded relationship between higher blood pressure and cardiovascular disease. Risk does not begin at 140/90; it generally increases as pressure rises, particularly when other risk factors are present.

The guideline also considered randomized trial evidence that lowering blood pressure can reduce cardiovascular events in selected adults at elevated risk. ACC/AHA translated that evidence into a lower definition of hypertension and a larger role for overall cardiovascular risk in decisions about monitoring and treatment.

That change did not mean that every person with a reading from 130/80 through 139/89 should receive a prescription. Under ACC/AHA, the significance of stage 1 hypertension depends on the repeated pattern and the person’s broader cardiovascular risk. A history of cardiovascular disease, a higher estimated ten-year risk, diabetes, kidney disease, or other factors can change the balance. Lower-risk situations may be managed with monitoring and lifestyle discussion rather than an immediate medication decision.

The lower threshold also makes a modest rise in pressure visible earlier. That can prompt a review of activity, sodium intake, alcohol, sleep, weight, smoking, diabetes, cholesterol, family history, and measurement technique. The trade-off is that a broader label can increase anxiety or expose people to treatment discussions when the expected benefit is small.

The American approach therefore accepts more labeling below 140/90 in exchange for earlier identification of elevated cardiovascular risk. The label by itself is not an instruction to start medication.

Why Europe retained 140/90

The European position starts with the same continuous-risk evidence but makes a different judgment about where the word hypertension should begin. ESC and ESH have emphasized that a diagnosis carries practical consequences and should correspond to a pressure range in which the expected benefit of medical treatment is sufficiently clear for the person being considered.

A higher diagnostic threshold does not make readings in the 130s irrelevant. The high-normal category identifies a range that may warrant closer observation, particularly when there are additional risk factors, evidence of organ effects, or a persistent pattern outside the clinic.

European guidance also gives substantial weight to confirming blood pressure beyond the examination room. A home average can reduce the influence of a stressful appointment. Ambulatory monitoring can show daytime and nighttime patterns, including pressure that rises outside the clinic or fails to fall during sleep. These methods do not make a diagnosis automatically; they provide better evidence for the pattern being assessed.

In practical terms, traditional European guidance draws a firmer line around the hypertension label and uses persistence, risk, measurement method, and the wider health picture to determine what follows. It can limit unnecessary labeling while still allowing earlier attention to people with more to gain.

The blood pressure chart, in both the American and European versions puts these categories side by side. It is useful when a monitor, website, or medical record uses a table that differs from the one seen previously.

AHA vs ESC hypertension: what changes in practice

The tables look far apart because ACC/AHA calls 130–139/80–89 stage 1 hypertension, while ESC/ESH calls most of that range high-normal. The practical decisions are closer than the labels suggest.

Both systems use repeated readings rather than a single result. Both consider total cardiovascular risk, kidney function, diabetes, previous cardiovascular disease, age, frailty, symptoms, and the person’s preferences. A reading in the 130s does not automatically lead to medication under ACC/AHA, just as a high-normal European reading does not automatically mean that no follow-up is needed.

At clearly higher office pressures, the approaches converge further. Persistent readings at or above 140/90 usually receive serious attention in both systems. The threshold used for home readings, the speed of follow-up, the role of risk estimates, and the treatment target can still differ.

Targets are separate from classification. A category describes a reading. A target describes a range that may offer an appropriate balance during treatment for a particular person. It depends on age, comorbidities, frailty, symptoms, measurement method, and tolerance. It should not be selected from a chart alone.

The article Is 130/85 high blood pressure? It depends which guideline you ask works through this exact example. The answer changes by framework, but the need for a reliable pattern does not.

European blood pressure guidelines after 2023

Search results sometimes use “ESC/ESH guidelines” as if they refer to one unchanged European document. The current picture is more layered.

The 2023 ESH guideline retained the familiar office classification of optimal, normal, high-normal, and grades 1 through 3 hypertension. The 2024 ESC guideline uses the term elevated blood pressure for a broader range below hypertension and keeps office hypertension at 140/90 mmHg or higher. It also sets out updated risk-based approaches to treatment and target ranges.

The 2024 ESC category of elevated blood pressure covers 120–139 mmHg systolic or 70–89 mmHg diastolic. This wording is broader than the traditional high-normal band, so the labels cannot be compared without checking which document and measurement setting are being used.

A European service may therefore describe the same result using the ESH grade table, the newer ESC elevated-blood-pressure language, or a national adaptation. That is not necessarily a disagreement about the measurement. It may reflect the document adopted by that service.

The practical question is: which guideline is being used, and did the number come from an office, home, or ambulatory measurement? That prevents a category label from being mistaken for a diagnosis.

Office, home, and ambulatory readings are not interchangeable

A cuff reading is affected by posture, rest time, cuff size, recent activity, talking, caffeine, nicotine, pain, stress, and a full bladder. The arm should be supported, and the cuff should fit the upper arm rather than being placed over thick clothing. An incorrect cuff size can systematically distort the result.

A clinic reading can rise because the setting feels tense. Anxiety during measurement can push the result upward without making the reading useless. A quiet rest period and repeated readings can provide a more representative office result, but the pattern outside the clinic may still be different.

Home monitoring provides another view. A health professional may request readings at set times over several days and use an average rather than the highest value. The seven-day home monitoring protocol, and how to actually finish it explains the routine without turning every number into a verdict.

A smartphone camera, a fingertip on a screen, or a phone app alone cannot measure blood pressure. Only a validated cuff can measure it. An app can record, organize, average, and share cuff readings, but it cannot replace the cuff or establish that the device is accurate.

Tonelva is designed for record-keeping. It lets you enter a cuff reading in three taps, view it against both ACC/AHA and ESC/ESH categories, separate morning and evening trends, and create a PDF for a care appointment. The reading still comes from the cuff, not the phone.

For technique, see Measuring blood pressure at home correctly, step by step. A consistent method can explain a change that initially looks like a change in health.

What to record for a useful appointment

Write down the date, time, systolic number, diastolic number, pulse if requested, and the arm used. Add a short note when something could affect the reading, such as exercise, poor sleep, pain, illness, caffeine, nicotine, or an unusually stressful event. Do not discard an unusual result simply because it does not fit the rest of the page.

Record whether the reading was taken before or after medication if the care team has asked for that information, but do not use the log to make a medication change. The purpose of the record is to show the pattern and its circumstances.

Morning and evening patterns can differ. Recording the time helps distinguish those periods instead of treating all readings as one undifferentiated list. Tonelva keeps those parts of the day separate and can export the record as a PDF; a paper Printable blood pressure log can work just as well.

A seven-day average can be more informative than a single low or high result. The 7-day home blood pressure average calculator can help with the arithmetic, but the result still needs the measurement context and the guideline being used.

Bring the readings, dates, technique notes, and questions to the professional managing your care. A category table should not be used by itself to make a medication decision.

When a reading needs urgent attention

A very high reading together with chest pain, breathlessness, weakness, vision change, or confusion means emergency care, not a diary entry. Do not wait for an app to classify it or rely on a chart. If a reading is very high without those symptoms, repeat it after a short, quiet rest and seek prompt clinical guidance if it remains high.

What the guidelines agree on

The shared message is stronger than the national labels make it appear. Blood pressure is a long-term pattern, not a single isolated number. Accurate measurement matters. Home or ambulatory monitoring can add information that a clinic reading misses. Risk factors matter alongside the pressure itself.

The guidelines also agree that lower is not automatically better for every person in every situation. Treatment has benefits and possible burdens, and targets must account for the person, the measurement method, and how the result feels in daily life.

The measurement method deserves special attention. An office value, a structured home average, and a 24-hour ambulatory profile answer different questions. A number without its setting, date, time, technique, and surrounding readings invites a false argument about which table is right.

Bottom line

ACC/AHA and ESC/ESH genuinely disagree about where the hypertension label begins. ACC/AHA uses 130/80 mmHg, while traditional ESC/ESH guidance uses 140/90 mmHg for office hypertension and identifies high-normal pressure below it. Neither threshold marks a sudden biological change.

Use the framework adopted by your health system, and record repeated readings from a validated cuff with their dates, times, settings, and technique notes. Keep morning and evening results identifiable. A phone can organize the record but cannot measure blood pressure. The useful evidence is the reliable pattern, interpreted in the correct framework—not a single number or an app label.